Mr Jackson King

Spokane (United States of America)

Follow

Contributor content

Temporal trends in first-line anticoagulation therapy for cancer-associated venous thromboembolism

Presentation

Temporal trends in first-line anticoagulation therapy for cancer-associated venous thromboembolism

ESC 365 is supported by

novartis

Explore sponsored resources